IDEAS home Printed from https://ideas.repec.org/a/zbw/espost/299546.html
   My bibliography  Save this article

Pharmacists as Strategic Leaders of Manufacturing Pharmaceutical Companies with Operations in South Africa

Author

Listed:
  • Nyeleti Mayimele, Nsovo
  • Hulisani Demana, Patrick
  • Godfrey Keele, Mothobi

Abstract

The manufacturing sector of the pharmaceutical industry has faced criticism for disparities in access to pharmaceuticals, especially within the context of past incidents and the COVID-19 pandemic. Balancing profitability with the public responsibility to produce affordable, safe and effective medicines is challenging. The World Health Organisation (WHO) recognises the significant role pharmacists play in discovering, manufacturing and dispensing medicines. Pharmacists are responsible for safeguarding pharmaceuticals at all levels of care and where medicines are used. The research aimed to assess the involvement of pharmacists in the strategic leadership of Multinational Pharmaceutical Companies (MPCs) operating in South Africa. The study assessed the presence of pharmacists, recognised as custodians of medicines, in the strategic leadership of pharmaceutical companies operating in South Africa but headquartered globally. A desktop review was done to assess the company profiles, including revenue, size, number of employees and professional backgrounds of the persons in strategic leadership, including board and executive levels. The pharmaceutical companies were headquartered in eleven countries across Asia (3), Africa (1), North America (1), and Europe (6). On average, these companies operated in 86.6 countries (SD ±46.2). The strategic leadership roles within MPCs were comprised of individuals with backgrounds in commerce, sciences, and engineering. Predominantly, professionals with backgrounds in commerce held significant representation in both board membership and executive leadership within these companies. Notably, only 3.2% (33 out of 1023) of leaders possessed a pharmacy qualification, with a mere 27% (9 out of 33) being female. This was the least represented professional background among the strategic leaders, and the likelihood was affected by gender. The pharmacists more likely to hold strategic positions were predominantly male, had additional qualifications, and were situated in specific countries like India and South Africa. Pharmaceutical companies are essential in producing medicines to address global healthcare needs, functioning as healthcare service providers. Strategic leaders in these companies guide the manufacturing sites’ strategic goals of the companies. The study’s outcomes revealed a restricted presence of pharmacists in leadership roles despite their typical responsibility for manufacturing sites. These pharmacists were often found to have limited authority and were excluded from pivotal decision-making processes, resulting in significant implications for patient welfare.

Suggested Citation

  • Nyeleti Mayimele, Nsovo & Hulisani Demana, Patrick & Godfrey Keele, Mothobi, 2023. "Pharmacists as Strategic Leaders of Manufacturing Pharmaceutical Companies with Operations in South Africa," EconStor Open Access Articles and Book Chapters, ZBW - Leibniz Information Centre for Economics, vol. 7(4), pages 200-209.
    • Handle: RePEc:zbw:espost:299546
    DOI: 10.61093/bel.7(4).200-209.2023
    as

    Download full text from publisher

    File URL: https://www.econstor.eu/bitstream/10419/299546/1/Mayimele-Pharmacists-as-strategic-leaders.pdf
    Download Restriction: no
    File URL: https://libkey.io/10.61093/bel.7(4).200-209.2023?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. María‐Florencia Amorelli & Isabel‐María García‐Sánchez, 2021. "Trends in the dynamic evolution of board gender diversity and corporate social responsibility," Corporate Social Responsibility and Environmental Management, John Wiley & Sons, vol. 28(2), pages 537-554, March.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Al-Najjar, Basil & Salama, Aly, 2022. "Mind the gap: Are female directors and executives more sensitive to the environment in high-tech us firms?," Technological Forecasting and Social Change, Elsevier, vol. 184(C).
    2. Mônica Cavalcanti Sá de Abreu & Romulo Alves Soares & Victor Daniel‐Vasconcelos & Vicente Lima Crisóstomo, 2023. "Does board diversity encourage an environmental policy focused on resource use, emission reduction and innovation? The case of companies in Latin America," Corporate Social Responsibility and Environmental Management, John Wiley & Sons, vol. 30(3), pages 1161-1176, May.
    3. Deepa Sharma & Suman Chakraborty & Ashwath Ananda Rao & Lumen Shawn Lobo, 2023. "The Relationship of Corporate Social Responsibility and Firm Performance: A Bibliometric Overview," SAGE Open, , vol. 13(1), pages 21582440231, March.
    4. Mauro Romano & Antonio Netti & Antonio Corvino & Marika Intenza, 2024. "Environmental innovation in healthcare industry: The moderating role of women on board in cost of debt," Corporate Social Responsibility and Environmental Management, John Wiley & Sons, vol. 31(3), pages 1921-1933, May.
    5. Fernando, Guy D. & Schneible, Richard A. & Zhang, Wei, 2024. "Institutional ownership and women in the top management team," Journal of Business Research, Elsevier, vol. 170(C).
    6. Rabiu Saminu Jibril & Muhammad Aminu Isa, 2025. "Corporate board diversity, environmental compliance, and occupational health and safety disclosure for achieving sustainable development goals in an emerging economy," Sustainable Development, John Wiley & Sons, Ltd., vol. 33(1), pages 652-667, February.
    7. Nerantzidis, Michail & Tzeremes, Panayiotis & Koutoupis, Andreas & Pourgias, Apostolos, 2022. "Exploring the black box: Board gender diversity and corporate social performance," Finance Research Letters, Elsevier, vol. 48(C).
    8. Wided Khiari & Houssein Ballouk & Wiem Chiba, 2025. "CSR Committee, Women on the Board, and Green Bond Issuance: Evidence from France," JRFM, MDPI, vol. 18(4), pages 1-18, March.
    9. Pochara Arayakarnkul & Pattanaporn Chatjuthamard & Sirimon Treepongkaruna, 2022. "Board gender diversity, corporate social commitment and sustainability," Corporate Social Responsibility and Environmental Management, John Wiley & Sons, vol. 29(5), pages 1706-1721, September.
    10. Praphada Srisuwan & Trairong Swatdikun & Shubham Pathak & Lidya Primta Surbakti & Alisara Saramolee, 2024. "Factors Influencing Key Audit Matter Reporting in the Stock Exchange of Thailand: Empirical Evidence from 2016–2020 Data," JRFM, MDPI, vol. 17(11), pages 1-18, November.
    11. Khwaja Naveed & Fahad Khalid & Cosmina Lelia Voinea, 2023. "Board gender diversity and corporate green innovation: An industry‐level institutional perspective," Corporate Social Responsibility and Environmental Management, John Wiley & Sons, vol. 30(2), pages 755-772, March.
    12. Nakajima, Kan & Shirasu, Yoko & Kodera, Eiji, 2025. "Tokenism in gender diversity on board of directors," Journal of the Japanese and International Economies, Elsevier, vol. 75(C).
    13. Hüseyin Temiz & Merve Acar, 2023. "Board gender diversity and corporate social responsibility (CSR) disclosure in different disclosure environments," Corporate Social Responsibility and Environmental Management, John Wiley & Sons, vol. 30(5), pages 2247-2264, September.
    14. Christianna Chimonaki & Stelios Papadakis & Christos Lemonakis, 2024. "Environmental, Social, Governance and Gen-der Diversity Under the Adoption of European Directive 2014/95/EU," Journal of Accounting and Management Information Systems, Faculty of Accounting and Management Information Systems, The Bucharest University of Economic Studies, vol. 23(1), pages 162-188, January.
    15. Rey Đặng & L.’Hocine Houanti & Michel Simioni & Jean-Michel Sahut, 2025. "The role of endogeneity in the relationship between board gender diversity and corporate social performance: evidence from a control function method," Annals of Operations Research, Springer, vol. 347(1), pages 333-365, April.
    16. Dorota Dobija & Claudia Arena & Łukasz Kozłowski & Joanna Krasodomska & Justyna Godawska, 2023. "Towards sustainable development: The role of directors' international orientation and their diversity for non‐financial disclosure," Corporate Social Responsibility and Environmental Management, John Wiley & Sons, vol. 30(1), pages 66-90, January.
    17. Alan Bandeira Pinheiro & Nágela Bianca do Prado & Gustavo Hermínio Salati Marcondes de Moraes & Flávio Hourneaux Junior, 2025. "Exploring the United Nations Global Compact adoption in a multi‐level perspective," Sustainable Development, John Wiley & Sons, Ltd., vol. 33(2), pages 2352-2363, April.
    18. Safiullah, Md & Akhter, Tanzina & Saona, Paolo & Azad, Md. Abul Kalam, 2022. "Gender diversity on corporate boards, firm performance, and risk-taking: New evidence from Spain," Journal of Behavioral and Experimental Finance, Elsevier, vol. 35(C).
    19. Vincent Tawiah & Reon Matemane & Babajide Oyewo & Tesfaye T. Lemma, 2024. "Saving the environment with indigenous directors: Evidence from Africa," Business Strategy and the Environment, Wiley Blackwell, vol. 33(3), pages 2445-2461, March.
    20. Jungwon Min & Gyunhee Kim, 2024. "Breaking gender stereotypes in management practices: Promoting paternity leave," Corporate Social Responsibility and Environmental Management, John Wiley & Sons, vol. 31(5), pages 3823-3835, September.

    More about this item

    Keywords

    Pharmaceutical industry; Pharmacists; Manufacturing; strategic leadership; listed companies; pharmacy leadership;
    All these keywords.

    JEL classification:

    • I11 - Health, Education, and Welfare - - Health - - - Analysis of Health Care Markets
    • L65 - Industrial Organization - - Industry Studies: Manufacturing - - - Chemicals; Rubber; Drugs; Biotechnology; Plastics
    • P46 - Political Economy and Comparative Economic Systems - - Other Economic Systems - - - Consumer Economics; Health; Education and Training; Welfare, Income, Wealth, and Poverty

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:zbw:espost:299546. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: ZBW - Leibniz Information Centre for Economics (email available below). General contact details of provider: https://edirc.repec.org/data/zbwkide.html .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.